Early CPAP use identifies subsequent adherence to CPAP therapy

Sleep

Volumn 30, Issue 3, 2007, Pages 320-324

  Budhiraja, Rohit ^a,b   Parthasarathy, Sairam ^a,b   Drake, Christopher L ^c   Roth, Thomas ^c   Sharief, Imran ^b   Budhiraja, Pooja ^b   Saunders, Victoria ^c   Hudgel, David W ^c  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

Adherence; Compliance, sex, race, age; Continuous positive airway pressure; CPAP; Obstructive sleep apnea; Sleep disordered breathing; Sleep related breathing disorder

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CONTROLLED STUDY; DEVICE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; TELEMETRY;

EID: 33947686783     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Budhiraja R, Quan SF. Sleep-disordered breathing and cardiovascular health. Curr Opin Pulm Med 2005;11:501-6.
2. Barbe F, Pericas J, Munoz A, et al. Automobile accidents in patients with sleep apnea syndrome. An epidemiological and mechanistic study. Am J Respir Crit Care Med 1998;158:18-22.
3. Kapur VK, Redline S, Nieto FJ, et al. The relationship between chronically disrupted sleep and healthcare use. Sleep 2002;25:289-96.
4. Weaver TE, Kribbs NB, Pack AI, et al. Night-to-night variability in CPAP use over the first three months of treatment. Sleep 1997;20:278-83.
5. Munoz A, Mayoralas LR, Barbe F, et al. Long-term effects of CPAP on daytime functioning in patients with sleep apnoea syndrome. Eur Respir J 2000;15:676-81.
6. Engleman HM, Martin SE, Deary IJ, et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994;343:572-5.
7. Montserrat JM, Ferrer M, Hernandez L, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 2001;164:608-13.
8. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;359:204-10.
9. Marti S, Sampol G, Munoz X, et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J2002;20:1511-8.
10. Engleman HM, Kingshort RN, Wraith PK, et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:461-7.
11. Sin DD, Mayers I, Man GC, et al. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest 2002;121:430-5.
12. Bachour A, Maasilta P. Mouth breathing compromises adherence to nasal continuous positive airway pressure therapy. Chest 2004;126:1248-54.
13. Drake CL, Day R, Hudgel D, et al. Sleep during titration predicts continuous positive airway pressure compliance. Sleep 2003;26:308-11.
14. Wilson DK, Ampey-Thornhill G. The role of gender and family support on dietary compliance in an African American adolescent hypertension prevention study. Ann Behav Med 2001;23:59-67.
15. Sung JC, Nichol MB, Venturini F, et al. Factors affecting patient compliance with antihyperlipidemic medications in an HMO population. Am J Manag Care 1998;4:1421-30.
16. Tardivel J. Gender differences in relation to motivation and compliance in cardiac rehabilitation. Nurs Crit Care 1998;3:214-9.
17. Augenbraun M, Bachmann L, Wallace T, et al. Compliance with doxycycline therapy in sexually transmitted diseases clinics. Sex Transm Dis 1998;25:1-4.
18. Katz BP, Zwickl BW, Caine VA, et al. Compliance with antibiotic therapy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis 1992;19:351-4.
19. Randall DE, Marshall JR, Brasure J, et al. Patterns in food use and compliance with NCI dietary guidelines. Nutr Cancer 1991;15:141-58.
20. Ayala C, Neff LJ, Croft JB, et al. Prevalence of self-reported high blood pressure awareness, advice received from health professionals and actions taken to reduce high blood pressure among US adults-Healthstyles 2002. J Clin Hypertens 2005;7:513-9.
21. Heurtin-Roberts S, Reisin E. The relation of culturally influenced lay models of hypertension to compliance with treatment. Am J Hypertens 1992;5:787-92.
22. Rechtschaffen A, Kales A, eds. A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages of Human Subjects. Los Angeles: Brain Information Service/Brain Research Institute, UCLA; 1968.
23. Lloberes P, Marti S, Sampol G, et al. Predictive factors of quality-of-life improvement and continuous positive airway pressure use in patients with sleep apnea-hypopnea syndrome: study at 1 year. Chest 2004;126:1241-7.
24. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147:887-95.
25. Stepnowsky CJ, Dimsdale JE. Dose-response relationship between CPAP compliance and measures of sleep apnea severity. Sleep Med 2002;3:329-34.
26. Rosenthal L, Gerhardstein R, Lumley A, et al. CPAP therapy in patients with mild OSA: implementation and treatment outcome. Sleep Med 2000;1:215-20.
27. Mortimore IL, Kochhar P, Douglas NJ. Effect of chronic continuous positive airway pressure (CPAP) therapy on upper airway size in patients with sleep apnoea/hypopnoea syndrome. Thorax 1996;51:190-2.
28. Lewis KE, Seale L, Bartle IE, et al. Early predictors of CPAP use for the treatment of obstructive sleep apnea. Sleep 2004;27:134-8.
29. Popescu G, Latham M, Allgar V, et al. Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long term use. Thorax 2001;56:727-33.
30. Parthasarathy S HP, Budhiraja, R, Habib MP, Quan SF. A national survey of the effect of sleep medicine specialist and American Academy of Sleep Medicine accreditation on management of obstructive sleep apnea. J Clin Sleep Med 2006;02:133-142.
31. Hudgel DW, Fung C. A long-term randomized, cross-over comparison of auto-titrating and standard nasal continuous airway pressure. Sleep 2000;23:645-8.
32. Fleck DE, Keck PE, Jr, Corey KB, et al. Factors associated with medication adherence in African American and white patients with bipolar disorder. J Clin Psychiatry 2005;66:646-52.
33. Aloia MS, Di Dio L, Ilniczky N, et al. Improving compliance with nasal CPAP and vigilance in older adults with OAHS. Sleep Breath 2001;5:13-21.
34. Chervin RD, Theut S, Bassetti C, et al. Compliance with nasal CPAP can be improved by simple interventions. Sleep 1997;20:284-9.
35. Likar LL, Panciera TM, Erickson AD, et al. Group education sessions and compliance with nasal CPAP therapy. Chest 1997;111:1273-7.
36. Massie CA, Hart RW, Peralez K, et al. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 1999;116:403-8.
37. Hui DS, Choy DK, Li TS, et al. Determinants of continuous positive airway pressure compliance in a group of Chinese patients with obstructive sleep apnea. Chest 2001;120:170-6.
38. Pepin JL, Krieger J, Rodenstein D, et al. Effective compliance during the first 3 months of continuous positive airway pressure. A European prospective study of 121 patients. Am J Respir Crit Care Med 1999;160:1124-9.
39. Reeves-Hoche MK, Meek R, Zwillich CW Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994;149:149-54.
40. Johnson MK, Carter R, Nicol A, et al. Long-term continuous positive airway pressure (CPAP) outcomes from a sleep service using limited sleep studies and daycase CPAP titration in the management of obstructive sleep apnoea/hypopnoea syndrome. Chron Respir Dis 2004;1:83-8.
41. McArdle N, Devereux G, Heidarnejad H, et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:1108-14.
42. Russo-Magno P, O'Brien A, Panciera T, et al. Compliance with CPAP therapy in older men with obstructive sleep apnea. J Am Geriatr Soc 2001;49:1205-11.